Kalvista Pharmaceuticals Inc (KALV)
Stock-Based Compensation
$5.38M
TTM · Period ending: · USD
KALV Stock-Based Compensation
Latest reported$5.38Mperiod ending
Latest reported$5.38Mperiod ending
KALV TTM Stock-Based Comp ($381.00K → $5.38M)
TTM stock-based compensation
High-resolution chart · PNG
KALV stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 5,379,000 | |
| -3,270,000 | |
| -660,000 | |
| -660,000 | |
| -2,999,000 | |
| 18,393,000 | |
| 18,494,000 | |
| 21,701,000 | |
| 18,661,000 | |
| 5,918,000 | |
| 3,207,000 | |
| 0 | |
| 2,642,000 | |
| 2,642,000 | |
| 5,419,000 | |
| 8,279,000 | |
| 5,637,000 | |
| 9,078,000 | |
| 7,542,000 | |
| 4,682,000 | |
| 4,682,000 | |
| 2,331,000 | |
| 2,212,000 | |
| 3,374,000 | |
| 4,448,000 | |
| 4,204,000 | |
| 3,879,000 | |
| 3,693,000 | |
| 2,966,000 | |
| 2,401,000 | |
| 1,889,000 | |
| 1,186,000 | |
| 1,060,000 | |
| 945,000 | |
| 659,933 | |
| 668,933 | |
| 759,933 | |
| 961,933 | |
| 1,303,000 | |
| 1,310,000 | |
| 1,035,000 | |
| 785,000 | |
| 617,000 | |
| 427,000 | |
| 440,000 | |
| 381,000 | |
| 272,000 |